PARK CITY, Utah — Segments that include patient pay or elective procedures are likely to be impacted by a volatile economic market, according to a speaker at Eyecelerator.
Kirsten Harmon Ingenito, MBA, CEO of Market Scope, gave an update on the ophthalmic market. She discussed the way financial markets have responded to recent government policy changes. While the overall ophthalmic market was worth $48.8 billion in 2024, and there is potential that some segments could see growth in the future, Ingenito said some parts of ophthalmology could struggle in an (Read more...)